SG149070A1 - Non-nucleotide reverse transcriptase inhibitors - Google Patents

Non-nucleotide reverse transcriptase inhibitors

Info

Publication number
SG149070A1
SG149070A1 SG200809639-8A SG2008096398A SG149070A1 SG 149070 A1 SG149070 A1 SG 149070A1 SG 2008096398 A SG2008096398 A SG 2008096398A SG 149070 A1 SG149070 A1 SG 149070A1
Authority
SG
Singapore
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleotide reverse
nucleotide
inhibitors
Prior art date
Application number
SG200809639-8A
Other languages
English (en)
Inventor
Christian Sund
Nathalie Roue
Stefan Lindstroem
Dmitry Antonov
Christer Sahlberg
Katarina Jansson
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400021A external-priority patent/SE0400021D0/xx
Priority claimed from SE0400585A external-priority patent/SE0400585D0/xx
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of SG149070A1 publication Critical patent/SG149070A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG200809639-8A 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors SG149070A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400021A SE0400021D0 (sv) 2004-01-08 2004-01-08 Non-nucleoside reverse transcriptase inhibitors
SE0400585A SE0400585D0 (sv) 2004-03-09 2004-03-09 NNRTI Antivirals

Publications (1)

Publication Number Publication Date
SG149070A1 true SG149070A1 (en) 2009-01-29

Family

ID=34752289

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200809639-8A SG149070A1 (en) 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors

Country Status (15)

Country Link
US (1) US7915295B2 (enExample)
EP (1) EP1701942B1 (enExample)
JP (1) JP4762917B2 (enExample)
AT (1) ATE451357T1 (enExample)
AU (1) AU2004312284B2 (enExample)
BR (1) BRPI0418306B8 (enExample)
CA (1) CA2550187C (enExample)
DE (1) DE602004024584D1 (enExample)
DK (1) DK1701942T3 (enExample)
EA (1) EA009700B1 (enExample)
ES (1) ES2337794T3 (enExample)
IL (1) IL176740A (enExample)
NZ (1) NZ548367A (enExample)
SG (1) SG149070A1 (enExample)
WO (1) WO2005066131A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538155A (ja) * 2002-09-05 2005-12-15 メディヴィル・アクチボラグ 非ヌクレオシド逆転写酵素インヒビター
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
US20060287316A1 (en) * 2005-04-27 2006-12-21 Ambrilia Biopharma Inc. Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
AU2006319716B2 (en) 2005-11-30 2012-02-02 Taimed Biologics, Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
AU2007254325B2 (en) * 2006-05-15 2012-05-10 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
CN102083793A (zh) 2006-09-21 2011-06-01 安布林生物制药公司 蛋白酶抑制剂
CN107438593B (zh) * 2015-01-30 2020-10-30 基因泰克公司 治疗化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486183B1 (en) * 1998-01-16 2002-11-26 Medivir Ab Antivirals
WO1999051613A1 (en) * 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
SE0100733D0 (sv) * 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
SE0102867D0 (sv) * 2001-08-28 2001-08-28 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
JP2005538155A (ja) * 2002-09-05 2005-12-15 メディヴィル・アクチボラグ 非ヌクレオシド逆転写酵素インヒビター

Also Published As

Publication number Publication date
AU2004312284A2 (en) 2005-07-21
CA2550187A1 (en) 2005-07-21
AU2004312284B2 (en) 2010-08-05
ATE451357T1 (de) 2009-12-15
JP2007519640A (ja) 2007-07-19
NZ548367A (en) 2010-06-25
JP4762917B2 (ja) 2011-08-31
EA009700B1 (ru) 2008-02-28
EP1701942A1 (en) 2006-09-20
HK1101400A1 (en) 2007-10-18
BRPI0418306A (pt) 2007-05-02
US20080070951A1 (en) 2008-03-20
ES2337794T3 (es) 2010-04-29
AU2004312284A1 (en) 2005-07-21
CA2550187C (en) 2012-08-07
EA200601289A1 (ru) 2006-12-29
US7915295B2 (en) 2011-03-29
DE602004024584D1 (de) 2010-01-21
WO2005066131A1 (en) 2005-07-21
BRPI0418306B1 (pt) 2018-09-18
IL176740A0 (en) 2006-10-31
EP1701942B1 (en) 2009-12-09
BRPI0418306B8 (pt) 2021-05-25
DK1701942T3 (da) 2010-04-06
IL176740A (en) 2011-09-27

Similar Documents

Publication Publication Date Title
IN2014CN03629A (enExample)
SG150511A1 (en) Viral polymerase inhibitors
NO20161397A1 (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer
IL196675A0 (en) Novel hiv reverse transcriptase inhibitors
HUS1400007I1 (hu) Dipeptidil-peptidáz inhibitorok
IL179398A0 (en) Dpp-ib inhibitors
GB2432609A (en) Method of expansion
IL188615A0 (en) Hiv reverse transcriptase inhibitors
MY155249A (en) Combinations comprising methotrexate and dhodh inhibitors
IL181969A0 (en) Dna-pk inhibitors
SG148179A1 (en) Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
SG149855A1 (en) N-channel transistor
EP1750696B1 (en) RETROVIRAL PROTEASE INHIBITORS RESISTING THEIR RESISTANCE
EP1732891A4 (en) RESISTANT PREVENTIVE INHIBITORS FOR RETROVIRAL PROTEASES
SG145667A1 (en) Chronograph watch
IL190081A0 (en) Nnrt inhibitors
SG149831A1 (en) Benzimidazole derivatives
SG149070A1 (en) Non-nucleotide reverse transcriptase inhibitors
EP1781443A4 (en) TAPS
EP1816194A4 (en) CANCER-SPECIFIC PROLIFERATION INHIBITORS
ZA200800185B (en) Hiv reverse transcriptase inhibitors
GB0421356D0 (en) Inhibitors
ZA200605395B (en) Non-nucleotide reverse transcriptase inhibitors
IL163598A0 (en) Dipyridodiazepinones as reverse transcriptase inhibitors
DE602005025674D1 (de) Inhibitor für darmpolypen